Dr. Ruch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1110 Sixth St
Traverse City, MI 49684Phone+1 231-392-8400Fax+1 231-935-7888
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2010 - 2013
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2007 - 2010
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2007
Certifications & Licensure
MI State Medical License 2010 - 2026
IL State Medical License 2007 - 2010- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsLow-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center.Petros Grivas, Sumana Devata, Rami Khoriaty, Philip S. Boonstra, Joshua Michael Ruch
Journal of Cancer Education. 2017-12-01 - 25 citationsA phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.David Bing Zhen, Kent A. Griffith, Joshua M. Ruch, Kevin Camphausen, Jason E. Savage
Investigational New Drugs. 2016-07-21 - 4 citationsA Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.Elizabeth J. Davis, Kent A. Griffith, Edward J. Kim, Joshua M. Ruch, Kevin McDonnell
American Journal of Clinical Oncology. 2015-11-03
Press Mentions
Former Senior FDA Official Dr. Rachel Sherman Joins Sema4 Board of DirectorsMarch 12th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
